Barclays
VXRT

Barclays’s Vaxart VXRT Stock Holding History

Barclays’s Portfolio VXRT Stock Details VXRT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-64,889
Closed -$49.1K – 5109
2023
Q1 		$49.1K Buy
64,889
+30,364
+88% +$28.2K ﹤0.01% 4452
2022
Q4 		$33.2K Sell
34,525
-621,592
-95% -$878K ﹤0.01% 4686
2022
Q3 		$1.43M Buy
656,117
+646,836
+6,969% +$2.23M ﹤0.01% 1967
2022
Q2 		$33K Sell
9,281
-11,168
-55% -$41.7K ﹤0.01% 4208
2022
Q1 		$103K Sell
20,449
-128,108
-86% -$649K ﹤0.01% 3766
2021
Q4 		$931K Buy
148,557
+97,542
+191% +$666K ﹤0.01% 2876
2021
Q3 		$407K Buy
51,015
+26,362
+107% +$217K ﹤0.01% 3288
2021
Q2 		$185K Sell
24,653
-20,094
-45% -$140K ﹤0.01% 3591
2021
Q1 		$271K Sell
44,747
-131,970
-75% -$1.02M ﹤0.01% 3560
2020
Q4 		$1.01M Buy
176,717
+40,019
+29% +$255K ﹤0.01% 2753
2020
Q3 		$909K Sell
136,698
-505
-0.4% -$4.5K ﹤0.01% 2777
2020
Q2 		$1.22M Buy
+137,203
New +$394K ﹤0.01% 2577
2016
Q3 		– Sell
-9
Closed – – 6817
2016
Q2 		$0 Hold
9
– – ﹤0.01% 6665
2016
Q1 		$0 Hold
9
– – ﹤0.01% 6469
2015
Q4 		$0 Hold
9
– – ﹤0.01% 6634
2015
Q3 		$0 Hold
9
– – ﹤0.01% 7080
2015
Q2 		$0 Hold
9
– – ﹤0.01% 7229
2015
Q1 		$0 Hold
9
– – ﹤0.01% 7286
2014
Q4 		$0 Hold
9
– – ﹤0.01% 7637
2014
Q3 		$0 Sell
9
-391
-98% -$11.2K ﹤0.01% 7844
2014
Q2 		$9K Buy
400
+391
+4,344% +$16.3K ﹤0.01% 6891
2014
Q1 		$1K Hold
9
– – ﹤0.01% 7493
2013
Q4 		$0 Hold
9
– – ﹤0.01% 7709
2013
Q3 		$0 Hold
9
– – ﹤0.01% 7636
2013
Q2 		$0 Buy
+9
New +$374 ﹤0.01% 7672

Other funds holding VXRT

CF
Cantor Fitzgerald New York $6.78B AUM 29.01% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RCMU
Rokos Capital Management (UK) London, United Kingdom $13.2B AUM 85.71% 1-Year Est. Return

Barclays's VXRT Position: Q2 2023 in Review

Barclays sold out of Vaxart (VXRT) in Q2 2023, closing a stake of 64,889 shares — an estimated $49.1K sold.

Barclays first reported a position in VXRT in Q2 2013 and held it in 25 quarters. The position peaked at $1.43M in Q3 2022. 111 funds tracked by Wall St. Rank hold VXRT as of Q2 2023.

  • Barclays reported no remaining Vaxart position as of Q2 2023 after selling out during the quarter.
  • Barclays sold 64,889 Vaxart shares in Q2 2023, an estimated $49.1K.
  • Barclays first reported a position in Vaxart in Q2 2013 and held it in 25 quarters.
  • Barclays's Vaxart position peaked at $1.43M in Q3 2022.
  • 111 funds tracked by Wall St. Rank held Vaxart as of Q2 2023.

Based on Barclays's 13F filing for Q2 2023, filed 3 Aug 2023.